145 related articles for article (PubMed ID: 34900024)
1. Identification of MATN3 as a Novel Prognostic Biomarker for Gastric Cancer through Comprehensive TCGA and GEO Data Mining.
Wang P; Xiao WS; Li YH; Wu XP; Zhu HB; Tan YR
Dis Markers; 2021; 2021():1769635. PubMed ID: 34900024
[TBL] [Abstract][Full Text] [Related]
2. Martrilin-3 (MATN3) Overexpression in Gastric Adenocarcinoma and its Prognostic Significance.
Wu PL; He YF; Yao HH; Hu B
Med Sci Monit; 2018 Jan; 24():348-355. PubMed ID: 29343680
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic value of MATN3 expression in gastric carcinoma: TCGA database mining.
Li D; Xu J; Dong X; Chen W; Pan L; Jiang H; Pan J; Huang Y
J Gastrointest Oncol; 2021 Aug; 12(4):1374-1383. PubMed ID: 34532095
[TBL] [Abstract][Full Text] [Related]
4. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
He XY; Zhao J; Chen ZQ; Jin R; Liu CY
Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
[TBL] [Abstract][Full Text] [Related]
5. Discovery and Validation of an Epithelial-Mesenchymal Transition-Based Signature in Gastric Cancer by Genomics and Prognosis Analysis.
Xu H; Wan H; Zhu M; Feng L; Zhang H; Su F
Biomed Res Int; 2021; 2021():9026918. PubMed ID: 34746312
[TBL] [Abstract][Full Text] [Related]
6. KRT15, INHBA, MATN3, and AGT are aberrantly methylated and differentially expressed in gastric cancer and associated with prognosis.
Zhang C; Liang Y; Ma MH; Wu KZ; Dai DQ
Pathol Res Pract; 2019 May; 215(5):893-899. PubMed ID: 30718100
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.
Liang L; Zhao K; Zhu JH; Chen G; Qin XG; Chen JQ
Oncol Rep; 2019 Aug; 42(2):615-628. PubMed ID: 31233188
[TBL] [Abstract][Full Text] [Related]
8. The phase separation of extracellular matrix protein matrilin-3 from cancer-associated fibroblasts contributes to gastric cancer invasion.
Huang Y; Xu X; Lu Y; Sun Q; Zhang L; Shao J; Chen D; Chang Y; Sun X; Zhuo W; Zhou T
FASEB J; 2024 Jan; 38(2):e23406. PubMed ID: 38193601
[TBL] [Abstract][Full Text] [Related]
9. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
10. Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery.
Lee J; Sohn I; Do IG; Kim KM; Park SH; Park JO; Park YS; Lim HY; Sohn TS; Bae JM; Choi MG; Lim DH; Min BH; Lee JH; Rhee PL; Kim JJ; Choi DI; Tan IB; Das K; Tan P; Jung SH; Kang WK; Kim S
PLoS One; 2014; 9(3):e90133. PubMed ID: 24598828
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
Liu J; Liu Z; Zhang X; Gong T; Yao D
BMC Cancer; 2019 Mar; 19(1):227. PubMed ID: 30866865
[TBL] [Abstract][Full Text] [Related]
12. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
13. Mining TCGA database for genes of prognostic value in gastric cancer microenvironment.
Lan Q; Wang P; Tian S; Dong W
J Cell Mol Med; 2020 Oct; 24(19):11120-11132. PubMed ID: 32818296
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of the Immune Regulator CXCR4 as a Novel Promising Target for Gastric Cancer.
Xue S; Ma M; Bei S; Li F; Wu C; Li H; Hu Y; Zhang X; Qian Y; Qin Z; Jiang J; Feng L
Front Immunol; 2021; 12():702615. PubMed ID: 34322132
[TBL] [Abstract][Full Text] [Related]
15. High expression of MRE11 correlates with poor prognosis in gastric carcinoma.
Li J; Su T; Yang L; Zhang C; He Y
Diagn Pathol; 2019 Jun; 14(1):60. PubMed ID: 31221177
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
17. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
Ma B; Li Y; Ren Y
Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
[TBL] [Abstract][Full Text] [Related]
18. High expression of COL5A2, a member of COL5 family, indicates the poor survival and facilitates cell migration in gastric cancer.
Tan Y; Chen Q; Xing Y; Zhang C; Pan S; An W; Xu H
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33739392
[TBL] [Abstract][Full Text] [Related]
19. CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker.
Amini M; Ghorban K; Mokhtarzadeh A; Dadmanesh M; Baradaran B
Life Sci; 2020 Aug; 254():117774. PubMed ID: 32407843
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of
Wang MQ; Yin QY; Chen YR; Zhu SL
Future Oncol; 2021 Dec; 17(35):4907-4923. PubMed ID: 34751593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
